BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 12932168)

  • 1. Restenosis after femoropopliteal PTA and elective stent implantation: predictive value of monocyte counts.
    Schillinger M; Exner M; Mlekusch W; Haumer M; Sabeti S; Ahmadi R; Schwarzinger I; Wagner O; Minar E
    J Endovasc Ther; 2003 Jun; 10(3):557-65. PubMed ID: 12932168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angioplasty and elective stenting of de novo versus recurrent femoropopliteal lesions: 1-year follow-up.
    Schillinger M; Mlekusch W; Haumer M; Sabeti S; Ahmadi R; Minar E
    J Endovasc Ther; 2003 Apr; 10(2):288-97. PubMed ID: 12877612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restenosis after percutaneous transluminal angioplasty in the femoropopliteal segment: the role of inflammation.
    Schillinger M; Haumer M; Schlerka G; Mlekusch W; Exner M; Ahmadi R; Minar E
    J Endovasc Ther; 2001 Oct; 8(5):477-83. PubMed ID: 11718406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Percutaneous revascularization of femoropopliteal artery disease: PTA and PTA plus stent. Results after six years' follow-up.
    Pozzi Mucelli F; Fisicaro M; Calderan L; Malacrea M; Mazzone C; Cattin L; Scardi S; Pozzi Mucelli R
    Radiol Med; 2003 Apr; 105(4):339-49. PubMed ID: 12835627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood fluidity and outcome after femoropopliteal percutaneous transluminal angioplasty (PTA): role of plasma viscosity and low platelet count in predicting restenosis.
    van der Loo B; Kovacevic T; Krieger E; Banyai S; Banyai M; Amann-Vesti BR; Jagacic D; Rousson V; Koppensteiner R
    Clin Hemorheol Microcirc; 2005; 32(2):159-68. PubMed ID: 15764824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Percutaneous transluminal angioplasty with or without stenting for femoropopliteal occlusions? A randomized controlled study.
    Zdanowski Z; Albrechtsson U; Lundin A; Jonung T; Ribbe E; Thörne J; Norgren L
    Int Angiol; 1999 Dec; 18(4):251-5. PubMed ID: 10811511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitinol stenting improves primary patency of the superficial femoral artery after percutaneous transluminal angioplasty in hemodialysis patients: a propensity-matched analysis.
    Kawamura Y; Ishii H; Aoyama T; Tanaka M; Takahashi H; Kumada Y; Toriyama T; Murohara T
    J Vasc Surg; 2009 Nov; 50(5):1057-62. PubMed ID: 19782527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized study to compare PTA alone versus PTA with Palmaz stent placement for femoropopliteal lesions.
    Grimm J; Müller-Hülsbeck S; Jahnke T; Hilbert C; Brossmann J; Heller M
    J Vasc Interv Radiol; 2001 Aug; 12(8):935-42. PubMed ID: 11487673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous angioplasty and stenting of the superficial femoral artery.
    Surowiec SM; Davies MG; Eberly SW; Rhodes JM; Illig KA; Shortell CK; Lee DE; Waldman DL; Green RM
    J Vasc Surg; 2005 Feb; 41(2):269-78. PubMed ID: 15768009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endovascular brachytherapy for prophylaxis of restenosis after femoropopliteal angioplasty: five-year follow-up--prospective randomized study.
    Wolfram RM; Budinsky AC; Pokrajac B; Potter R; Minar E
    Radiology; 2006 Sep; 240(3):878-84. PubMed ID: 16926331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endovascular brachytherapy for prophylaxis of restenosis after femoropopliteal angioplasty : results of a prospective randomized study.
    Minar E; Pokrajac B; Maca T; Ahmadi R; Fellner C; Mittlböck M; Seitz W; Wolfram R; Pötter R
    Circulation; 2000 Nov; 102(22):2694-9. PubMed ID: 11094034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High plasma heparin cofactor II activity protects from restenosis after femoropopliteal stenting.
    Schillinger M; Exner M; Sabeti S; Mlekusch W; Amighi J; Handler S; Quehenberger P; Kalifeh N; Wagner O; Minar E
    Thromb Haemost; 2004 Nov; 92(5):1108-13. PubMed ID: 15543340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Stenting of failing above-knee femoropopliteal percutaneous transluminal angioplasty].
    Pedersen G; Laxdal E; Wirsching J; Aune S
    Tidsskr Nor Laegeforen; 2003 Sep; 123(17):2437-8. PubMed ID: 14562780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous transluminal angioplasty (PTA) alone versus PTA with balloon-expandable stent placement for short-segment femoropopliteal artery disease: a metaanalysis of randomized trials.
    E Y; He N; Wang Y; Fan H
    J Vasc Interv Radiol; 2008 Apr; 19(4):499-503. PubMed ID: 18375292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of smoking on restenosis during the 1st year after lower-limb endovascular interventions.
    Schillinger M; Exner M; Mlekusch W; Haumer M; Sabeti S; Ahmadi R; Wagner O; Minar E
    Radiology; 2004 Jun; 231(3):831-8. PubMed ID: 15163820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Routine stent implantation vs. percutaneous transluminal angioplasty in femoropopliteal artery disease: a meta-analysis of randomized controlled trials.
    Kasapis C; Henke PK; Chetcuti SJ; Koenig GC; Rectenwald JE; Krishnamurthy VN; Grossman PM; Gurm HS
    Eur Heart J; 2009 Jan; 30(1):44-55. PubMed ID: 19028778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Femoropopliteal arteries: immediate and long-term results with a Dacron-covered stent-graft.
    Ahmadi R; Schillinger M; Maca T; Minar E
    Radiology; 2002 May; 223(2):345-50. PubMed ID: 11997536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraarterial (192)Ir high-dose-rate brachytherapy for prophylaxis of restenosis after femoropopliteal percutaneous transluminal angioplasty: the prospective randomized Vienna-2-trial radiotherapy parameters and risk factors analysis.
    Pokrajac B; Pötter R; Maca T; Fellner C; Mittlböck M; Ahmadi R; Seitz W; Minar E
    Int J Radiat Oncol Biol Phys; 2000 Nov; 48(4):923-31. PubMed ID: 11072147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukins and inflammatory markers in in-stent restenosis after femoral percutaneous transluminal angioplasty.
    Araújo PV; Ribeiro MS; Dalio MB; Rocha LA; Viaro F; Dellalibera Joviliano R; Piccinato CE; Évora PR; Joviliano EE
    Ann Vasc Surg; 2015; 29(4):731-7. PubMed ID: 25725274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular brachytherapy with 192Ir after femoropopliteal stent implantation in high-risk patients: twelve-month follow-up results from the Vienna-5 trial.
    Wolfram RM; Budinsky AC; Pokrajac B; Pötter R; Minar E
    Radiology; 2005 Jul; 236(1):343-51. PubMed ID: 15987985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.